Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval ...
After hours: January 14 at 5:13:24 PM EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback